Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
705 Biodistribution and shedding analysis following RP1 oncolytic immunotherapy dosing in patients from the IGNYTE clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.